Skip to content

Comparative Effects of Action Observation and Motor Imagery on Upper Limb in Chronic Stroke Patients

Comparative Effects of Action Observation and Motor Imagery Training on Upper Limb Function in Chronic Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06108440
Enrollment
44
Registered
2023-10-31
Start date
2023-08-03
Completion date
2024-02-01
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Upper Extremity Paresis, Motor Activity

Keywords

Stroke, Upper Extremity Paresis, Motor Activity

Brief summary

To Compare effects of action observation and motor imagery training on upper limb function in chronic stroke patients.

Detailed description

The study is Randomized controlled trial. The study will be conducted on 44 stroke patients. The study will be conducted in Civil Hospital Shujaabad and Riphah rehabilitation centre Lahore. Patients will be divided into Group A (n = 20) and Group B (n = 20) using a randomization through computer generated numbers program. Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks. Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks. For the pre- and post-evaluation of all participants, Fugl-Meyer Assessment Upper Extremity (FMA UE) and Wolf Motor Function Test (WMFT) will be used. Data will be analyzed by using SPSS (Statistical package for Social Sciences) 25 version.

Interventions

Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks.

Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients will be divided into Group A (n = 20) and Group B (n = 20) using a randomization through computer generated numbers program. Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks. Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks.

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with chronic stroke by a neurologist * 03 months post stroke * Score 1+ on modified ashworth scale * Having a score of 24 or higher in the Mini-Mental State Examination

Exclusion criteria

* Patient with neurological condition other than stroke e.g. Parkinson's or multiple sclerosis * Presence of an attached artificial pacemaker * Presence of a metal implant in the brain * Presence of visual impairment * Presence of unilateral neglect in Line bisection test (25) * Use of antipsychotic drugs

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment Upper Extremity (FMA UE):6 monthsFugl-Meyer Assessment Upper Extremity (FMA UE): FMA UE is a detailed evaluation tool that quantitatively measures motor function, balance, sensation, joint range of motion, and pain in stroke hemiplegic patients
Wolf Motor Function Test (WMFT):6 monthsWolf Motor Function Test (WMFT): The Wolf motor function test is a tool to evaluate upper extremity motor function in hemiplegic patients. It has 17 tasks with a score range from 0-5. The inter-rater reliability of the function score is 0.88 and the inter-rated reliability of performance time is 0.97

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026